Acadia Pharmaceuticals
ACAD
ACAD
306 hedge funds and large institutions have $7.9B invested in Acadia Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 93 increasing their positions, 98 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% more funds holding
Funds holding: 266 → 306 (+40)
5% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 98
1.46% less ownership
Funds ownership: 94.48% → 93.03% (-1.5%)
Holders
306
Holding in Top 10
9
Calls
$55.4M
Puts
$44.6M
Top Buyers
| 1 | +$104M | |
| 2 | +$47.7M | |
| 3 | +$44.8M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$28.2M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$25.1M |
Top Sellers
| 1 | -$142M | |
| 2 | -$69.3M | |
| 3 | -$64.2M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$42.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$33.3M |